Dr. Arellano's primary research focus is in the development of novel therapies for older adults with acute leukemias and myelodysplastic syndromes and immune-based therapies for hematological malignancies.
Get the latest thought leadership on AML delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life
AML stories, AML clinical trials, AML 101 articles and events with AML
Thanks to our HealthTree Community for AML Sponsors: